Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Boyce

Showing results (331-340 of 344) with videos related to

Pageof 35
Sort By:
Toxicologic Pathology|May 16, 2013
Cytokines associated with increased erythropoiesis in Sprague-Dawley rats administered a novel hyperglycosylated analog of recombinant human erythropoietinDina A Andrews, Hisham K Hamadeh, Yudong D He, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of MalariaManuel de Lera Ruiz, Paola Favuzza, Zhuyan Guo, et al.
Circulation|September 14, 2007
Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery diseaseAamir Javaid, Daniel H Steinberg, Ashesh N Buch, et al.
International Journal of Obesity (2005)|July 22, 2009
Socioeconomic position, macroeconomic environment and overweight among adolescents in 35 countriesP Due, M T Damsgaard, M Rasmussen, et al.
Science (New York, N.Y.)|November 13, 1998
An essential role for ectodomain shedding in mammalian developmentJ J Peschon, J L Slack, P Reddy, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of MK-5661, a Once-Daily Oral Na<sub>V</sub>1.8 Inhibitor for the Treatment of PainChristopher J Bungard, Michael J Breslin, Christopher W Boyce, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2011
Pharmacological characterization of a novel α2C-adrenoceptor agonist N-[3,4-dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1, 4-benzoxazin-6-yl]-N-ethyl-N'-methylurea (compound A)Michel R Corboz, Maria A Rivelli, Kevin D McCormick, et al.
Circulation|May 24, 2012
Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantationKeith D Aaronson, Mark S Slaughter, Leslie W Miller, et al.
Nature Medicine|January 13, 2026
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosisBrendan M Crowley, Helena I Boshoff, Aidan Boving, et al.
Viruses|July 27, 2024
Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological ProfilingNadine Alvarez, Gregory C Adam, John A Howe, et al.
Pageof 35

Showing results (331-340 of 344) with videos related to

Sort By:
Pageof 35
Toxicologic Pathology|May 16, 2013
Cytokines associated with increased erythropoiesis in Sprague-Dawley rats administered a novel hyperglycosylated analog of recombinant human erythropoietinDina A Andrews, Hisham K Hamadeh, Yudong D He, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of MalariaManuel de Lera Ruiz, Paola Favuzza, Zhuyan Guo, et al.
Circulation|September 14, 2007
Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery diseaseAamir Javaid, Daniel H Steinberg, Ashesh N Buch, et al.
International Journal of Obesity (2005)|July 22, 2009
Socioeconomic position, macroeconomic environment and overweight among adolescents in 35 countriesP Due, M T Damsgaard, M Rasmussen, et al.
Science (New York, N.Y.)|November 13, 1998
An essential role for ectodomain shedding in mammalian developmentJ J Peschon, J L Slack, P Reddy, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of MK-5661, a Once-Daily Oral Na<sub>V</sub>1.8 Inhibitor for the Treatment of PainChristopher J Bungard, Michael J Breslin, Christopher W Boyce, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2011
Pharmacological characterization of a novel α2C-adrenoceptor agonist N-[3,4-dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1, 4-benzoxazin-6-yl]-N-ethyl-N'-methylurea (compound A)Michel R Corboz, Maria A Rivelli, Kevin D McCormick, et al.
Circulation|May 24, 2012
Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantationKeith D Aaronson, Mark S Slaughter, Leslie W Miller, et al.
Nature Medicine|January 13, 2026
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosisBrendan M Crowley, Helena I Boshoff, Aidan Boving, et al.
Viruses|July 27, 2024
Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological ProfilingNadine Alvarez, Gregory C Adam, John A Howe, et al.
Pageof 35